Funding
Open Access funding enabled and organized by Projekt DEAL. This study was supported by Celgene, a Bristol Myers Squibb Company, in collaboration with Acceleron Pharma Inc., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.